What is Global Artemisinine Market?
The Global Artemisinine Market is a vast and dynamic sector that deals with the production, distribution, and consumption of Artemisinine, a compound derived from the sweet wormwood plant, Artemisia annua. This market is of significant importance due to the medicinal value of Artemisinine, which is primarily used in the treatment of malaria. The market operates on a global scale, with key players spread across various regions, including Europe, Asia, and Africa. The market's value was estimated at US$ 62 million in 2023 and is projected to reach US$ 78 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 3.3%. This growth is driven by the increasing demand for Artemisinine in the pharmaceutical industry, coupled with advancements in extraction and production techniques.
Extraction from Artemisia annua, Semisynthetic Artemisinine in the Global Artemisinine Market:
The Global Artemisinine Market is segmented based on the source of Artemisinine, which includes extraction from Artemisia annua and semisynthetic Artemisinine. Extraction from Artemisia annua is the most common method and accounts for over 82% of the market share. This method involves harvesting the plant and extracting the Artemisinine using various techniques. On the other hand, semisynthetic Artemisinine is produced in a laboratory setting, which allows for more control over the production process and potentially higher yields. Both methods have their advantages and disadvantages, and their usage depends on various factors such as cost, availability of raw materials, and production capacity.
Injections, Tablets, Others in the Global Artemisinine Market:
Artemisinine is primarily used in the pharmaceutical industry, where it is formulated into different products such as injections and tablets. Injections are often used in severe cases of malaria, where immediate action is required. Tablets, on the other hand, are used for less severe cases and for preventive measures. Other uses of Artemisinine include its incorporation in dietary supplements due to its potential health benefits. The choice of product depends on various factors such as the severity of the disease, patient preference, and cost. The demand for these products is driven by the prevalence of malaria, especially in regions such as Africa and Asia, where the disease is endemic.
Global Artemisinine Market Outlook:
The Global Artemisinine Market outlook indicates a steady growth in the coming years. In 2023, the market was valued at US$ 62 million and is expected to reach US$ 78 million by 2030, growing at a CAGR of 3.3%. The top four manufacturers globally hold a share of over 65%, indicating a high level of market concentration. Europe is the largest market, accounting for about 45% of the total market share, followed by India and Africa, each with about 40%. In terms of product segmentation, extraction from Artemisia annua is the largest segment, accounting for over 82% of the market share. This data provides a snapshot of the current market scenario and can be used to make informed decisions and strategies for future growth.
| Report Metric | Details |
| Report Name | Artemisinine Market |
| Accounted market size in 2023 | US$ 62 million |
| Forecasted market size in 2030 | US$ 78 million |
| CAGR | 3.3% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Guilin Pharmaceutical, CAT KHANH, Novanat Bioresource, BEEPZ, KPC Pharmaceuticals, BIONEXX, Guangxi xiancaotang, Sanofi, Natural Bio-engineering, Kerui nanhai |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
